IDEX Corporation provided earnings guidance for the year 2022. Full year 2022 organic sales growth is projected to be approximately 10%, with a 9% to 10% organic sales increase in the third quarter of 2022 versus the prior year period. The Company expects full year 2022 reported EPS attributable to IDEX of $7.19 to $7.29 (adjusted EPS attributable to IDEX of $7.88 to $7.98) and third quarter 2022 reported EPS attributable to IDEX of $1.80 to $1.85 (adjusted EPS attributable to IDEX of $1.98 to $2.03).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
215.2 USD | -0.18% | -3.23% | -0.90% |
16/05 | IDEX Biometrics Completes Upsized NOK55 Million Share Placement | MT |
08/05 | Declaration of Voting Results by IDEX Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.90% | 1.63TCr | |
-6.09% | 1.38TCr | |
+20.11% | 651.82Cr | |
-6.34% | 509.72Cr | |
+1.35% | 451.36Cr | |
+7.28% | 313.48Cr | |
+31.76% | 191.27Cr | |
+84.87% | 156.66Cr | |
+17.17% | 100.46Cr | |
-6.33% | 87Cr |
- Stock Market
- Equities
- IEX Stock
- News IDEX Corporation
- IDEX Corporation Provides Earnings Guidance for the Year 2022